Source: Pharmacy Times articles
The indication is for adult patients with multiple myeloma who are refractory to lenalidomide and have previously received at least 1 line of therapy.
Read More
by | Apr 11, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
The indication is for adult patients with multiple myeloma who are refractory to lenalidomide and have previously received at least 1 line of therapy.
Read More